Clinical Trial Update: The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.

View source ↗

Summary

This clinical trial update describes the BARCODE 1 study, which uses genetic profiling to guide targeted screening for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Prostate Cancer | Status: ACTIVE_NOT_RECRUITING